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Abstract.  Epiphyseal chondrocytes cultured in a 
medium containing  10%  serum may be maintained  as 
three dimensional aggregates and differentiate termi- 
nally into hypertrophic cells. There is an attendant ex- 
pression of genes encoding type X  collagen and high 
levels of alkaline phosphatase activity. Manipulation of 
the serum concentration to optimal levels of 0.1 or 
0.01% in this chondrocyte pellet culture system results 
in formation of features of developing cartilage ar- 
chitecture which have been observed exclusively in 
growth cartilage in vivo. Cells are arranged  in 
columns radiating  out from the center of the tissue, 
and can be divided into distinct zones corresponding 
to the recognized stages of chondrocyte differentiation. 
Elimination  of the optimal serum concentration in a 
chemically defined medium containing  insulin 
eliminates the events of terminal differentiation of de- 
freed cartilage architecture.  Chondrocytes continue to 
enlarge into hypertrophic cells and synthesize type X 
collagen mRNA and protein, but in the absence of the 
optimal serum concentration,  alkaline phosphatase ac- 
tivity does not increase and the cells retain a random 
orientation.  Addition of thyroxine to the chemically 
defined medium containing insulin and growth hor- 
mone results in dose-dependent increases in both type 
X  collagen synthesis and alkaline phosphatase activity, 
and reproduces the optimal serum-induced morpho- 
genesis of chondrocytes into a columnar pattern. 
These experiments demonstrate the critical role of 
thyroxine in cartilage morphogenesis. 
T 
ERMINAL differentiation  of  chondrocytes  into  hy- 
pertrophic  cells  is  an  obligatory  step in  the  endo- 
chondral  ossification  pathway that occurs during em- 
bryonic bone development, longitudinal  bone growth, and 
fracture  healing.  This  terminal  differentiation  process  is 
marked by a several-fold increase in cell volume (11), syn- 
thesis of type X collagen,  and high" levels of alkaline phos- 
phatase activity. The net result of this developmental process 
is an increase in length of the growing bone and the mineral- 
ization of the surrounding  cartilage matrix.  This mineralized 
extracellular  matrix of cartilage provides the scaffold for the 
deposition of new bone matrix by invading osteoblasts. 
The identification  of factors regulating  this  critical  de- 
velopmental pathway of the skeleton has been hampered by 
lack of a suitable in vitro model. It is well-established that 
chondrocytes lose their polygonal  morphology and dedif- 
ferentiate  when  placed  in  traditional  monolayer  cultures 
in vitro on tissue culture plastic, a problem which is exacer- 
bated by low cell density or multiple passages (4-6, 25). Al- 
though suspending chondrocytes in culture media or agarose 
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stabilizes the chondrocyte phenotype and permits terminal 
differentiation  into hypertrophic  cells (3, 6, 25), the lack of 
a three-dimensional  tissue architecture  prevents morphogen- 
esis of growing cartilage and its study as an organized tissue. 
We have resolved this dilemma by modification of a simple 
method of chondrocyte culture which maintains  cells as an 
aggregated  cell pellet, thereby more closely approximating 
the three-dimensional  environment of developing cartilage in 
vivo under strict control of culture conditions (13). Although 
this aggregation of cells is not distinguished immediately fol- 
lowing centrifugation,  after 21 days in culture a sizeable car- 
tilage nodule  develops  (Fig.  1). When cultured in medium 
containing  10% serum, chondrocytes maintained  as cell pel- 
lets terminally  differentiate  into hypertrophic cells, express 
genes encoding type X collagen,  and exhibit high levels of 
alkaline phosphatase activity, all of which can be reversibly 
inhibited  by exogenous addition  of TGF-/~I (2). 
The potential  utility  of this  model to investigate  events 
linked  to chondrocyte differentiation  is limited due to the 
presence of serum and precludes the identification of specific 
factors responsible for the regulation  of key steps of this se- 
quential  differentiation  process. We and others have there- 
fore attempted to establish culture conditions which will al- 
low chondrocyte differentiation  to proceed in  chemically 
defined media (7, 19, 23). The present investigation demon- 
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of culture in chemically defined DME:FI2 medium supplemented 
with insulin (5  #g/ml).  The original cell pellet at the beginning 
of the culture period was barely visible on gross inspection. Bar, 
lmm. 
strates that optimization of the serum concentration to 0ol or 
0.01%  in  this  three-dimensional  culture  system  results  in 
morphogenesis  of developing  cartilage  architecture  which 
have  been observed previously only in growth cartilage in 
vivo.  Cells are arranged  in columns radiating  out from the 
center of the tissue, and can be divided into distinct zones 
corresponding to the recognized stages of chondrocyte dif- 
ferentiation.  Elimination of serum in this chemically defined 
medium containing insulin as the sole regulatory factor re- 
sults  in the blockade of terminal differentiation.  Although 
chondrocytes continue to enlarge into hypertrophic  cells and 
synthesize type X  collagen mRNA and protein,  in the ab- 
sence of serum alkaline phosphatase  activity  does not in- 
crease and the cells retain a random orientation. Addition of 
thyroxine to chemically defined medium containing insulin 
and growth hormone, however, results in a dose-dependent 
increase in both type X collagen synthesis and alkaline phos- 
phatase activity,  and morphogenesis of chondrocytes into a 
columnar pattern  reminiscent of the in vivo growth plate. 
Materials and Methods 
Materials 
Fitton-Jackson modified  BGFo medium, CMRL  1066 medium, DME,  a 
combination  of DME: Ham's F12 medium (1:1), MEM, Ham's F12 medium, 
penicillin-streptomycin,  PBS, sodium pyruvate,  FBS, and recombinant hu- 
man insulin-like  growth factor I and H (IGF-I and IGF-II) (all from GIBCO, 
Grand Island, NY); Collagcoase P and purified bacterial collagenase (Boeh- 
ringer Mannheim, Indianapolis,  IN);  L-ascorbic  acid phosphate (Wako 
Biochemicals,  Richmond, VA); ITS  +  Premix (Collaborative Research, 
Bedford,  MA);  L-thyroxine,  beta-aminopmprionitrile  (BAPN) I,  pepsin, 
p-nilmphenol  phosphate, and Folin's reagent (all from Sigma Chemical Co., 
St. Louis, MO); [32p]dCTP and [U-14C]-proline (Amersham International, 
Amersham, UK); EN3HANCE  (New England Nuclear,  Boston, MA); rat 
growth hormone was a gift from the National Hormone and Pituitary Pro- 
gram (National  Institute of Arthritis, Diabetes,  and Digestive and Kidney 
Diseases and National Institutes of Health, Bethesda,  MD); recombinant 
porcine TGF-~I was a gift from Michael Sporn and Anita Roberts (National 
Cancer Institute,  and National Institutes of Health, Bethesda, MD); bone 
morphogenetic protein-3 (BMP-3) was purified from demineralized bovine 
matrix as previously described (17, 24); recombinant human BMP-4 was a 
gift from Dr.  Glenn Hamrnonds (Genentech, South San Francisco, CA); 
recombinant  human OP-1 (BMP-7) was a gift from T. Kuber Sampath (Crea- 
tive Biomolecules,  Hopkinton, MA). 
Chondrocyte Isolation 
Chondrocytes were isolated from the resting zone of the distal femoral 
growth cartilage of two-d-old neonatal Sprague-Dawley  rats by collagenaso 
digestion.  The distal femora were exposed by dissection under loupe mag- 
nification.  Adherent soft tissues were stripped away and the reserve zone 
of the epiphysis removed by dissection.  The cartilage fragments containing 
the reserve zone cbondrocytes  were washed three times in PBS containing 
1% penicillin/streptomycin  and digested for 4 h in a 0.3 % solution of Col- 
lagenase P in PBS in a shaking water bath at 37°C. The solution containing 
the isolated cells  was filtered through 70-# mesh and the cells recovered by 
centrifugation at 1D00 rpm at 4°C and resuspended in culture medium at 
a final concentration of 160,000 cells/ml. 
Three-dimensional Pellet Culture 
Chondrocytes were cultured as a three-dimensional cell pellet as previously 
described (2). Briefly,  1-ml allquots  containing 160,000  cells each were 
added to 15-ml conical polypropylene centrifuge tubes and the cells pelleted 
by centrifugation at 1,000 rpm for 5 min at 4°C.  The cultures were then 
maintained at 37°C in 95% oxygen and 5% CO2 in a humidified incubator. 
Medium was changed every other day after the third day. 
Pellets  were  maintained up  to  21  days  in  DME:F12  medium  sup- 
plemented with 50/~g/ml L-ascorbic acid phosphate (10), 100 #g/ml sodium 
pyruvate,  1% (vol/vol) penicillin-streptomycin,  and either heat-inaetivated 
FBS or a defined media supplement yielding a final concentration of 6.25 
#g/mi bovine insulin, 6.25 #g/ml transferrin, 6.25 ng/mi selenous acid, 1.25 
mg/mi bovine serum albumin, and 5.35 #g/ml linoleic  acid. To study the 
effect  of  the composition  of  the chemically defined media on chondrocyte 
differentiation,  pellets  were also  maintained in the following five culture 
media supplemented as described above: Fitton-Jackson modified BGJb me- 
dium; CMRL 1066 medium; Ham's FI2 medium; DME alone; and MEM. 
In some experiments,  the following factors were substituted one at a time 
for insulin and/or added to insulin-containing  media for the entire 21-d cul- 
ture period:  recombinant human IGF-I (20 ng/mi); recombinant buman 
IGF-II (20 ng/mi); bovine insulin (100 ng/ml); rat growth  hormone (50 
ng/ml); recombinant  porcine TGF-/~I (10 ng/mi); L-thyroxine (1-100 ng/ml); 
purified bovine BMP-3 (10 ng/mi); recombinant human BMP-4 (10 ng/ml); 
recombinant human BMP-7 (10 ng/mi); and BAPN (100 #g/ml). These fac- 
tors were re-added with each change of the culture medium. 
Tissue Morphology 
Pellets  were fixed in 10% neutral buffered  formalin, dehydrated  through 
graded alcohols, and embedded in glycol methacrylate. 3-# sections per- 
pendicular to the short axis of the pellets were cut on a glass knife and 
stained with toluldine blue for light microscopy. 
Northern Blotting 
20-30 pooled samples per group were snap frozen and total cellular RNA 
extracted by homogenization in 6 M guanidine HCI, followed by cesium 
chloride gradient centrifugation  and sequential lithium  chloride and lithium 
chloride/ethanol precipitation. 5  t~l of total cellular RNA per lane were 
1. Abbreviations used in this paper: BAPN, beta-aminoproprionitrile;  BMP, 
bone morphogenetic protein; GAPDH,  glyceraldehyde  phosphate dehy- 
drogenase. 
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was transferred  to nylon membranes  and crosslinked to the filter by ex- 
posure to ultraviolet light. Radiolabeling of cDNA probes with [32p]dCTP 
was performed  using the random priming technique. Membranes ware pre- 
hybridized, hybridized, and washed by the method of Church and Gilbert 
(8), and exposed to radiographic film at -70°C using intensifying screens. 
To examine the endogenous expression of BMP genes in intact growth 
cartilage, total cellular RNA was extracted from the entire growth cartilage 
of  pooled distal femoral epiphyses obtained from 2-d-old neonatal Sprague- 
Dawley rats by the above method. 
cDNA Probes 
The following cDNA sequences were used to examine gene expression by 
Northern hybridization: pRC2, encoding 600 bp of the amino terminus of 
the rat alpha I(II) collagen gene (14); pSAMI0h, encoding 600 bp of exon 
3 and the 3' untranslated  region of the mouse type X collagen gene (1); 
and a  Pstl fragment  of the rat glyceraldehyde phosphate  dehydrogenase 
(GAPDH) cDNA for assessment of equivalence of RNA loading. 
Collagen Labeling and Extraction 
Cultures were treated with 100 #g/rul of BAPN for 20 rain before labeling 
with 5 #Ci/ml of [U-14C]-proline for the final 48 h of the culture period. 
Labeled collagens were extracted according to previously published meth- 
ods (6,  12). Briefly, labeled  pellets  were homogenized  in 0.5  N  acetic 
acid and digested with 1 mg/ml pepsin in 0.5 N acetic acid for 24 h at 4°C 
before inactivation of the pepsin by the addition of Tris to 50 mM and titra- 
tion to neutral pH with concentrated NaOH using phenol red as an indica- 
tor. Pepsin-resistant material was extracted for an additional 24 h in 0.15 M 
NaCI containing 20 mM DTT and 50 mM Tris-HC1 at pH 7.4 in the pres- 
ence of protease inhibitors (5 mM EITrA, 1 mM PMSF, 1 mM PABA, and 
5 mM NEM). Pepsin digests and DTT extracts ware combined and concen- 
trated  in a Centricon-30  concentrator  with a molecular  weight cutoff of 
30000. Aliquots of  labeled collagen (10,000 cpm per sample) were analyzed 
by SDS/PAGE on 4-20% gradient gels under reducing conditions.  Some 
samples were digested with 2.5 units of purified bacterial collagenase for 
1 h at 37°C prior to gel electrophoresis. Gels ware processed for fluorogra- 
phy with EN3HANCE and exposed to radiographic  film at  -70°C. 
To examine collagen synthesis in explant cultures of intact growth carti- 
lage, the hypertrophic zones of  both the distal femoral ephiphyses of  2-d-old 
neonatal rats ware'removed and cultured for 3 d in DME:F12 medium con- 
taining 10% FBS. Collagens were then labeled and extracted exactly as de- 
scribed above. 
Alkaline Phosphatase Activity 
Pellets were homogenized in 2 ml of  ice-cold 0.15 M NaCI containing 3 mM 
NaHCO3 (pH 7.4) with three 10-s  bursts using a Polytron homogenizer and 
centrifuged at 20,000 g for 30 min at 4°C. The supernatants ware assayed 
for alkaline phosphatase activity in 0.1 M sodium barbital buffer (pH 9.3) 
using p-nitrophenyl phosphate as a substrate as previously described (21). 
The amount of protein contained  in the enzyme extracts was determined 
(16), and the enzyme activity expressed as units of alkaline phosphatase ac- 
tivity per mg protein.  1 unit of alkaline phosphatase was defined as the en- 
zyme activity that liberated  1 #mol p-nitrophenol/30  rain at 37°C per mg 
protein. 
Statistical Analysis 
One-way analysis of variance (ANOVA) was used to assess the effect of the 
measured variables on alkaline phosphatase activity. Statistical significance 
between pairs of means within a group was determined by multiple t tests 
after adjusting the significance level for multiple comparisons by the Bon- 
ferroni method. 
Results 
Reducing the Serum Concentration in 
the Media Facilitates  Morphogenesis of  Columnar 
Cartilage Architecture 
Chondrocytes cultured in DME:F12 medium supplemented 
with 10 % serum acquired a hypertrophic morphology by day. 
21 of the culture period, as previously demonstrated (2) (Fig. 
2 a). It is noteworthy that perichondrium-like  layer of fiat- 
tened proliferating  cells  surrounded  the tissue.  Cells cul- 
tured in DME:F12 containing insulin in place of serum also 
acquired a hypertrophic morphology by day 21, but in the ab- 
sence of serum, no perichondrium-like layer of cells formed 
on the outside of the pellet (Fig.  2 f). 
To determine the minimal concentration of serum which 
would support full terminal differentiation of chondrocytes 
in vitro, cells were cultured in DME:F12 with serum concen- 
trations of less than  10%.  Surprisingly,  histologic analysis 
of pellets maintained for 21 d in minimal serum concentra- 
tions of 0.1 or 0.01% revealed that chondrocytes became or- 
ganized  in  a  columnar  pattern,  with the columns of cells 
radiating outward from the center of the pellet (Fig. 2, c and 
d).  This columnar architecture  remarkably  resembled the 
appearance of developing growth plate cartilage in vivo. The 
columns consisted of at least two discrete zones of differen- 
tiating cells, with the hypertrophic zone located on the inner 
aspect of the pellet and the proliferative zone located in the 
middle region. This columnar architecture produced by cul- 
turing cells under optimal serum conditions was disrupted 
by withholding ascorbic acid from the medium (Fig.  2 e), 
or by inhibiting  collagen crosslinking  by addition of beta- 
aminoproprionitrile  (Fig.  2 g). 
In the pellets maintained  in  10%  serum,  an envelope of 
flattened perichondrium-like cells ~3-5 cells thick was ob- 
served around the exterior of the pellet (Fig. 2 a). As the se- 
rum  concentration  decreased to  1%,  the thickness  of this 
perichondrium-like  layer decreased to 2-3 cell layers (Fig. 
2 b). At serum concentrations of 0.1 and 0.01%, this flattened 
layer of cells could no longer be identified (Fig. 2, c and d). 
Type X collagen gene expression was detectable by day 14 
and persisted through day 21 in 10% serum-treated cultures 
(Fig. 3). In cultures maintained in chemically defined media 
containing insulin in place of serum, type X collagen gene 
expression was present as early as day 14, but did not reach 
levels comparable to 10% serum-treated specimens until day 
21.  Reducing the serum concentration  modestly increased 
the level of type X collagen gene expression by day 21 of the 
culture period (Fig. 4). 
Synthesis of type X  collagen protein in the presence of 
10% serum was also apparent by day 14, but was only faintly 
detectable by day 21 (Fig. 5, lane 5). The ratio of type X col- 
lagen to type II collagen protein was increased in the insulin- 
treated cells compared to the 10% serum-treated cells by day 
21 (Fig. 5, lanes 1 and 5). Reducing the serum concentration 
appeared to increase the level of type X collagen protein syn- 
thesized by the cells at day 21 (Fig.  5~ lanes 1-5). 
Alkaline  phosphatase  activity  increased  significantly  in 
10%  serum-treated  cultures  compared  to  insulin-treated 
controls by day  14 (p <  0.01),  and remained  significantly 
elevated over controls by day 21 (/7 < 0.001) (Fig. 6). Alkaline 
phosphatase  activity  reached  maximum  levels in  cultures 
treated with 10% serum, decreased moderately as the serum 
concentration was reduced to 0.01%,  then fell precipitously 
as serum was completely removed and replaced with insulin 
(Fig.  7). 
One-way analysis of variance (ANOVA) confirmed a sig- 
nificant effect of serum concentration  on resulting alkaline 
phosphatase activity (17 <  0.001).  Pairwise comparisions of 
means confirmed that the insulin-treated group exhibited sig- 
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ance  of chondroeytes main- 
tained in pellet cultures for 21 
days in DME:F12 media sup- 
plemented  with  decreasing 
concentrations of serum: (A) 
10% FBS; (B) 1% FBS; (C) 
0.1% FBS; (D) 0.01% FBS; (E) 
0.1%  FBS  minus L-ascorbic 
acid  phosphate; (F)  insulin 
alone (5 #g/ml); (G) 0.1% ser- 
um plus beta-aminoproprioni- 
trile (100 ng/ml); (H) insulin 
(5  #g/lad) minus L-ascorbic 
acid  phosphate.  The  arrow- 
heads in A and B identify the 
perichondrium-like  layer  of 
cells surrounding the cell pel- 
let. Bar, 100 #m. 
nificantly less alkaline phosphatase activity at day 21 than all 
other serum-treated specimens (p <  0.01). 
Thyroxine Is the Serum Factor That Regulates 
Morphogenesis  of Columnar Cartilage 
Addition of rat growth hormone (50 ng/ml) to insulin-con- 
taming media inhibited differentiation of these cells into hy- 
pertrophic chondrocytes and did not alter the random orien- 
tation of cells previously observed in the absence of serum 
(Fig. 8 a). Growth hormone treatment also did not result in 
a  noticeable increase in pellet size,  type X  collagen syn- 
thesis, or alkaline phosphatase activity compared to insulin- 
containing medium alone.  When thyroxine was added to 
chemically defined media containing growth hormone and 
insulin, however, the inhibitory effect of growth hormone on 
chondrocyte  hypertrophy was reversed. At a concentration of 
100 ng/ml, thyroxine administration reproduced the serum- 
induced organization of chondrocytes into longitudinal col- 
umns (Fig. 8 b). Likewise, thyroxine etfected dose-respon- 
sive increases in both type X collagen synthesis (Fig. 5, lanes 
10-12) and alkaline phosphatase activity (Fig. 9). One-way 
ANOVA confirmed  that thyroxine concentration significantly 
increased resulting alkaline phosphatase activity (p < 0.001). 
Chondrocyte Hypertrophy  in the Absence of Serum Is 
Dependent on the Formulation  of the Culture Media 
The acquisition of the hypertrophic morphology by chon- 
drocytes cultured in insulin-supplemented medium was de- 
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X collagen by chondrocytes in pellet cultures maintained for 7, 14, 
and 21 days in the presence of 10% FBS or insulin (5 #g/ml). 
pendent on the formulation of the culture medium used. Only 
cells cultured in DME or a 1:1 combination of DME:F12 me- 
dium demonstrated widespread morphologic evidence of hy- 
pertrophy (Fig.  10, c and d). Cells cultured in insulin-con- 
taining  Fitton-Jackson  modified  BGJb  medium,  CMRL 
1066 medium, MEM, and Ham's F12 medium did not show 
consistent  morphologic  evidence  of cellular  hypertrophy 
(Fig.  10, a, b, e, and f). 
Similarly, only cells cultured in DME:F12 or DME alone 
displayed evidence  of  type X collagen gene expression by day 
21 (Fig. 11). Unexpectedly, this level of type X gene expres- 
sion was noticeably greater in DME:F12 medium than DME 
alone.  Ceils  cultured in insulin-containing Fitton-Jackson 
modified BGJb medium, CMRL 1066 medium, MEM, and 
Ham's F12 medium demonstrated no type X collagen gene 
expression by day 21, even on overexposed autoradiographs. 
Although alkaline phosphatase activity was significantly 
elevated in  DME  or DME:F12  medium compared to the 
other formulations (p <  0.001)  (Fig.  12),  this  activity re- 
mained at essentially baseline levels compared to serum- 
treated or thyroxine-treated cultures. 
Insulin/IGF Is Required for Continued 
Chondrocyte Survival, but Does Not Stimulate 
Terminal Differentiation 
In the absence of serum, replacement of insulin with recom- 
Figure 5.  SDS/PAGE (4-20%  gradient  gel)  analysis of [14C]- 
proline-labeled proteins extracted from chondroeyte pellets as de- 
scribed under Materials and Methods. Unless otherwise indicated, 
all cultures were maintained for 21 days in DME:F12 medium sup- 
plemented  with  L-aseorbic acid  phosphate  (50 /~g/ml), sodium 
pyruvate (100 ttg/ml) and the following components: 5 tzg/ml insu- 
lin (lane I); 0.01% FBS (lane 2); 0.1% FBS (lane 3); 1% FBS (lane 
4); 10% FBS (lane 5); 5 tLg/ml  insulin in DME medium alone (lane 
6); 5 ~g/ml insulin in DME:F12 medium (lane 7); same sample 
as in lane 7, digested with purified bacterial eollagenase (1 mg/mi) 
at 37"C for 30 rain prior to eleetropboresis (lane 8); intact growth 
cartilage from neonatal rat distal femur maintained as an explanted 
organ culture for 3 d (lane 9); 5 ttg/ml insulin and 50 ng/ml rat 
growth hormone (lane 10); 5 tzg/ml insulin, 50 #g/ml rat growth 
hormone, and 1 ng/ml L-thyroxine (lane 11); 5 ~tg/mi insulin, 50 
ng/ml rat growth hormone, and 100 ng/ml L-thyroxine (lane 12). 
binant human IGF-I (20 ng/ml),  IGF-II (20 ng/ml),  or a 
lower dose of insulin (100 ng/ml) did not result in a delete- 
rious effect  on cell survival, but ehondrocyte  hypertrophy  did 
not occur (data not shown). Attempts to substitute rat growth 
hormone (50 ng/ml), recombinant porcine TGF-~  (10 ng/ 
ml), purified bovine BMP-3 (10 ng/ml), recombinant human 
BMP-4 (10 ng/ml), and recombinant human OP-1 (BMP-7) 
(10 ng/ml) for insulin uniformly resulted in failure of cells 
to survive and proliferate within the first few days of the cul- 
ture period. 
Of interest is the observation that addition of 10 ng/ml of 
BMP-4 or BMP-7 to insulin-containing DME:F12 medium 
effected a striking increase in pellet size by day 21 (data not 
shown). Histologic examination revealed large areas of hy- 
pertrophic cells in the center of the pellet, indicating an am- 
plified anabolic response to BMP-4 and BMP-7 without inhi- 
Alkaline Phoephatlme  Activity Over 21 Day Culture Period 
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Figure 4. Expression of genes 
encoding type II collagen and 
type X collagen by chondro- 
cytes in pellet cultures main- 
tained for 21 days in the pres- 
ence of 0.01% to 10% FBS or 
insulin (5 #g/ml). 
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Figure 6. Alkaline phosphatase activity at 7, 14, and 21 d in cultures 
maintained in chemically defined DME:FI2 medium supplemented 
with insulin (5 ~tg/ml). Differences between means for serum- and 
insulin-treated cultures were significant both at Day 14 (p < 0.001) 
and Day 21 (p < 0.001). 
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Figure 7.. Alkaline phosphatase activity at day 21 in cultures main- 
tained in DME:F12 media in the presence of 0.01 to 10% FBS or 
insulin (5 #g/ml). One-way ANOVA confirmed a significant effect 
of serum concentration on resulting alkaline phosphatase activity 
(p < 0.001). The insulin-treated cultures demonstrated significantly 
less alkaline phosphatase activity at day 21 than all other serum- 
treated specimens (p < 0.001). 
bition of terminal differentiation. As reported previously for 
serum-containing media (2), addition of TGF-/$1 (10 ng/ml) 
to insulin-containing media reduced the final size of the pel- 
let compared to controls, and also inhibited terminal differ- 
entiation of these cells. 
Discussion 
The organization of proliferating chondrocytes into longi- 
tudinal columns is a critical event during the development 
and growth of the skeleton. During the early stages of em- 
bryogenesis, the condensation of mesenchyme into cartilage 
Figure 8. (A) Chondrocyte morphology at day 21 in pellet cultures 
in which rat growth hormone (50 ng/ml) was added to chemically 
defined media containing insulin (5/zg/ml). Lack of  cellular hyper- 
trophy and random orientation of the cells were noted. (B) Higher 
power photomicrograph of  pellet cultures in which L-thyroxine  (100 
ng/ml) has been added to chemically defined media containing both 
growth hormone (50 ng/ml) and insulin (5/~g/ml). The chondro- 
cytes have organized into columns of flattened cells resembling the 
proliferative zone of the growth plate in vivo. 
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Figure 9. Alkaline phosphatase activity at day 21 in cultures treated 
with thyroxine in the presence of growth hormone (50 ng/ml) and 
insulin (5/~g/ml). One-way ANOVA confirmed a significant effect 
of thyroxine concentration on resulting alkaline phosphatase activ- 
ity (p < 0.001). 
is followed by organization of this tissue into longitudinal ar- 
rays of flattened, proliferative cells which impose pattern on 
subsequent limb and vertebral growth. This columnar archi- 
tecture is maintained throughout the developmental period 
and into early adulthood as the growth plates of  the vertebrae 
and long bones. Disorganization of these columns is often 
seen  in  association  with  disorders  of  longitudinal  bone 
growth (18, 22). 
Our results indicate that factors present in serum are re- 
sponsible for organization of this columnar architecture in 
growing cartilage. The observation that optimal serum con- 
centrations of 0.1 to 0.01% have a profound effect on tissue 
organization  suggests  that  the  responsible  serum  factors 
must be active at very low concentrations, and therefore may 
be hormonal in nature. 
It is well known from the early studies of Evans and col- 
leagues that growth hormone is of paramount importance in 
the regulation of skeletal growth and maturation (15), there- 
fore we initially examined the effect of this anterior pituitary 
hormone on terminal chondrocyte differentiation. The re- 
suits  of these  experiments revealed that  growth  hormone 
alone has no pronounced effects on the longitudinal column 
architecture of chondrocytes. Because thyroxine is known to 
have synergistic effects with growth hormone during endo- 
chondral ossification (20,  21) and has recently been shown 
to stimulate type X collagen synthesis and alkaline phospha- 
tase activity in suspension cultures of chick embryo chon- 
drocytes (7, 19), we investigated the effect of thyroxine sup- 
plementation of  chemically defined media containing growth 
hormone and insulin.  Thyroxine supplementation not only 
recreated the serum-induced organization of chondrocytes 
into columns, but also produced attendant increases in both 
type X collagen synthesis and alkaline phosphatase activity 
to levels equivalent to those achieved with optimal serum. 
These results strongly suggest that thyroxine is the serum 
factor responsible for facilitating the cellular and molecular 
events of terminal chondrocyte differentiation observed in 
optimal serum cultures, including morphogenesis of colum- 
nar  cartilage.  This  observation also  illuminates  potential 
pathophysiological mechanisms involved the well-recognized 
The Journal of Cell Biology, Volume  126, 1994  1316 Figure  10  Morphologic  ap- 
pearanea of  chondroeytes  main- 
tained in pellet cnimres for 21 
days  in  various  formulations 
of chemically  defined  media 
supplemented  with  insulin 
(5/~g/ml).  (A) Fitton-Jackson 
modified BGJb medium;  (B) 
CMRL  1066 medium;  (C) 
DME; (D) DME:FI2 medium 
(l:l);  (E)  MEM; (F)  Ham's 
F12 medium.  Bar,  100 #m. 
clinical disorder of slipped capital femoral epiphysis which 
is common among children with hypothyroidism (26). 
The mechanism by which chondrocytes form these longi- 
tudinal columns of cells is not known, but is likely to be re- 
lated to interactions between the chondrocyte cytoskeleton 
and the extracellular matrix proteins surrounding the cell. 
This mechanism could conceivably involve integrins,  since 
it has recently been shown that the B1 integrin mediates the 
attachment of chondrocytes to type I and type II collagen (9). 
Future investigations will  likely focus on the specific role 
Alkaline Phosphatue Activity In Serum-Free Media 
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Figure 11. Expression of genes 
encoding type II collagen and 
type X collagen by chondro- 
cytes in pellet cultures main- 
tained  for  21  d  in  various 
formulations  of  chemically 
defined media containing  in- 
sulin (5 #g/ml). 
Figure 12. Alkaline phosphatase activity at day 21 in cultures main- 
tained for 21 d in various formulations of  chemically defined media 
containing insulin (5 #g/ml). One-way ANOVA  confirmed a signifi- 
cant effect of media formulation on resulting alkaline phosphatase 
activity (p < 0.001). Both DME and DME:FI2 media yielded sig- 
nificantly higher alkaline phosphatase activity than other formula- 
tions (p < 0.01), but were not significantly different from each other 
(p > 0.05). 
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play in regulating  type X collagen synthesis, alkaline phos- 
phatase activity,  and the morphogenesis  of columnar ear- 
tilage. 
It  was  of interest  to  observe  the  formation  of a  peri- 
chondrium-like layer around the exterior of the cell pellet in 
cultures  maintained  in  serum concentrations  greater than 
0.1%.  This perichondrial  structure  may  be  related to the 
presence of cell adhesion proteins in the serum. This layer 
is not necessary  for continued growth of the aggregate  as 
elimination of serum effected even larger increases in pellet 
size despite the absence of this periehondrium. 
Current data also demonstrate that the events of terminal 
chondrocyte differentiation are uncoupled when serum is re- 
moved from the culture media.  In the presence of insulin 
alone, chondrocytes maintain the ability to increase their in- 
tracellular volume, indicating that chondrocyte hypertrophy 
is a default pathway that does not require exogenous signals. 
The long lag period (21 days) between the beginning of insu- 
lin treatment  and the onset of hypertrophy  suggests that the 
role of insulin in regulating  chondrocyte hypertrophy  is per- 
haps permissive rather than instructive. All of the informa- 
tion necessary for cellular enlargement to occur is resident 
in the resting cells. 
At the high doses used in these experiments, insulin has 
been reported to bind to both the insulin receptor and the 
IGF-I receptor, suggesting that both pathways might require 
activation to permit chondrocyte hypertrophy  to occur.  In 
this regard, it is noteworthy that when the insulin concentra- 
tion was reduced or replaced with IGF-I or IGF-H, chon- 
drocyte viability was maintained, but there was no cellular 
hypertrophy. 
The modest elevation in gene expression for type X colla- 
gen combined with the noticeable increase in type X colla- 
gen protein as the serum concentration decreased suggests 
the possibility that 0.01 to 0.1% serum represents  the opti- 
mum culture conditions for chondrocyte differentiation.  Ai- 
though  we  have  not  directly  evaluated  transcriptional  or 
translational  regulation of the type X collagen gene in these 
studies, it is possible that specific factors present in serum 
may inhibit transcription  or translation of this gene when 
present in larger concentrations at the higher serum levels. 
Received for publication 22 November 1993 and in revised form 23 May 
1994. 
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